IKBKG and metabolic dysfunction-associated steatohepatitis: Moreover, NEMO protects the liver against chronic inflammation, progression of nonalcoholic steatohepatitis, and hepatocarcinogenesis (Luedde et al., 2007; Kondylis et al., 2017).